Announces Successful Completion

Related by string. Announce Successful Completion * ANNOUNCES . ANNOUNCE . announce : Announces Second Quarter . Announces Third Quarter . Announces Fourth Quarter / SUCCESSFUL . suc cessful . successful : Determine Successful Bidder . Successful exploitation allows . Successful exploitation requires / comple tion . completions : neared completion . Nears Completion * *

Related by context. All words. (Click for frequent words.) 88 Announces Completion 88 Announces Commencement 86 Announces Successful 86 Successfully Completes 85 Announces Termination 85 Completes Successful 85 Announce Completion 85 Announces Closing 85 Announces Proposed 85 Closes Sale 84 Completes Initial 84 Updates Status 83 Finalizes Acquisition 83 Closes Acquisition 83 Closes Previously Announced 83 Announces Receipt 82 Announces Signing 82 Announces Initiation 82 Consummates 82 Completes Acquisition 82 Announces Preliminary 82 Announce Receipt 82 Announces Shareholder Approval 82 Closes Acquisition Of 81 Reports Positive 81 Completes Purchase 81 Secures Financing 81 Enters Into Agreement 81 Announces Issuance 81 Finalizes Agreement 81 Completes Sale 81 Completes 81 Successfully Closes 81 Enters Agreement 81 Extends Expiration Date 81 Announces Acquisition 80 Completes Merger 80 Board Authorizes 80 Announces Expiration 80 Completes Previously Announced 80 Successfully Completed 80 Signs Agreements 80 Jointly Announce 80 Announces Stockholder Approval 80 Receives Favorable 80 Completes Private Placement 80 Extends Tender Offer 80 Completes Financing 80 Shareholders Approve Acquisition 80 Announces Redemption 80 Completes Refinancing 80 Increases Size 80 Commences 80 Announces Filing 79 Attains 79 Discontinues 79 Announce Commencement 79 Acquires Assets 79 Stockholders Approve 79 Announces Private Placement 79 Enters Into Definitive Agreement 79 Stockholders Approve Merger 79 Announces Refinancing 79 Finalizes 79 Announces Favorable 79 Enters Into 79 Announces Formation 79 Provides Update 79 Provides Update Regarding 79 Terminates Contract 79 Completes Divestiture 79 Receives Notice 79 Announces Divestiture 79 Completes Tender Offer 79 Files Shelf Registration Statement 79 Receives Patent 79 Announces Positive 79 Commences Tender Offer 78 Exercises Option 78 Announces Revised 78 Announces Effective Date 78 Amends Terms 78 Announces Definitive Agreement 78 Closes Second Tranche 78 Subsidiary Acquires 78 Completes Transition 78 Completes Merger With 78 Signs Definitive Agreement 78 Announces Cancellation 78 Completes Redemption 78 Announces Postponement 78 Completes Acquisitions 78 Provides Updates 78 Successfully Complete 78 Significantly Expands 78 Successfully Concludes 78 Q3 Loss Widens 78 Secures Funding 78 Shareholders Approve 78 Closes Financing 78 Announces Early Termination 78 Announces Pricing 78 Subsidiary Enters 78 Receives Notification 78 Expands Scope 78 Completes Integration 78 Receives Approval 78 Announce Signing 78 Announce Successful Completion 78 Announces Expanded 78 Shareholders Approve Merger 78 Announces Stock Repurchase 78 Completes Conversion 78 Restructures Debt 77 Acquire Assets 77 Extends Maturity 77 Aquires 77 Completes Installation 77 Terminates 77 Receives Regulatory 77 Completes Purchase Of 77 Announces Adjournment 77 Completes Enrollment 77 Further Strengthens 77 Achieves Significant 77 Announces Non Brokered 77 Completes Sale Of 77 Acquires Controlling Interest 77 Q4 Loss Narrows 77 Announces Additions 77 Q2 Loss Widens 77 Achieves Milestone 77 Confirms Receipt 77 Submits Application 77 Renegotiates 77 Wins Approval 77 Announces Licensing Agreement 77 Obtains 77 Completes Recapitalization 77 Announce Expiration 77 Subsidiary Receives 77 Provides Operational Update 77 Announces 77 Receives Confirmation 77 Q2 Loss Narrows 77 Enter Into 77 Reports Receipt 77 Announces Launch 77 Closes Private Placement 77 Commences Cash 77 Successfully Completes Tender Offer 77 Expand Relationship 77 Previously Announced 77 Announces Consummation 77 Q1 Loss Widens 77 Announce Agreement 77 Strengthens Its 77 Subsidiary Signs 77 Announces Organizational Changes 77 Strengthens Balance Sheet 77 Enters Into Strategic 77 Receives Commitment 77 Reconfirms 77 Q4 Loss Widens 77 Announces Resumption 77 Files Registration Statement 76 Reduces Debt 76 Reaches Agreement 76 Announces Underwriters Exercise 76 Provides Clarification 76 Completes Patient Enrollment 76 Nears Completion 76 Announces Appointment 76 Completes Transaction 76 Net Loss Widens 76 Awarded Patent 76 Q3 Loss Narrows 76 Files Patent Application 76 Announce Merger Agreement 76 Amends Credit 76 Announces Departure 76 Settles Litigation 76 Announces FDA Clearance 76 Signs Agreement 76 Announces Resignation 76 Initiates 76 Secures Additional 76 Announces Addition 76 Finalizes Sale 76 Obtains Approval 76 Shareholders Approve Sale 76 Announces Expansion 76 Q1 Loss Narrows 76 Receives Positive 76 Completes Asset 76 Completes Expansion 76 Redeems 76 More Than Doubles 76 Announces Intent 76 Strengthens Position 76 Subsidiary Completes 76 Furthers 76 Signs Definitive 76 Signs License Agreement 76 Signs Contract 76 Finalizes Purchase 76 Announces Availability 76 Signs Licensing Agreement 76 Annouces 76 Board Unanimously Rejects 76 Formalizes 76 Announces Enhancements 76 Executes Agreement 76 Updates Shareholders 75 Announces Intention 75 Restructures 75 Seeks Approval 75 Acquirer Company 75 Receives Conditional Approval 75 Sinks Lower 75 Terminates Agreement 75 Receives NASDAQ 75 Releases Third Quarter 75 Successful Completion 75 Announces Tender Offer 75 Updates Guidance 75 Provides Preliminary 75 Signs Long Term 75 Signs Option Agreement 75 Receives Conditional 75 Acquires 75 Net Loss Narrows 75 Announces Repurchase 75 Amends Agreement 75 Completes Restructuring 75 Signs Lease 75 Significantly Increases 75 Discloses 75 Signs Merger Agreement 75 Enters Into Exclusive 75 Announces License Agreement 75 Announce License Agreement 75 Signs Purchase Agreement 75 Announces Publication 75 Extends Relationship 75 Receives Clearance 75 Corporation Announces Pricing 75 Introduces Next Generation 75 Announces Presentation 75 Successfully Tests 75 Closes Merger 75 Increases Ownership 75 Signs MOU 75 Gets Approval 75 Enters Into Agreements 75 Monetizes 75 Initiates Phase II 75 Launches Enhanced 75 Renews Agreement 75 Announces Recapitalization 75 Streamlines Operations 75 Introduces Enhanced 75 Releases Second Quarter 75 Commences Operations 75 Continues Aggressive 75 Announces Share Repurchase 75 Enters Strategic 75 Temporarily Suspends 75 Completes Second Tranche 75 Posts Wider Loss 75 Announce Availability 75 Posts Strong 75 Regains Compliance 75 Announces Proposed Acquisition 75 Spins Off 74 Awarded Contract 74 Secures Long Term 74 Enters Into Merger Agreement 74 Receives Certification 74 Commences Phase 74 Signs LOI 74 Expands Capabilities 74 Shareholders Approve Merger Agreement 74 Issues Statement Regarding 74 Inks Pact 74 Doubles Size 74 Commences Offering 74 Complete Merger 74 Ink Deal 74 Launches Next Generation 74 Wins Contract 74 Expands Portfolio 74 Enrolls First 74 Announce Initiation 74 Sign Definitive Agreement 74 Announce Joint Venture 74 Changes Name 74 Provides Guidance 74 Receives Shareholder Approval 74 Jumps Higher 74 Submits Proposal 74 Secures Contract 74 Awarded Multi 74 Reports Profitable 74 Realigns 74 Continues Expansion 74 Reaches Settlement Agreement 74 Adopts Shareholder Rights 74 Q2 Profit Rises 74 Expands Presence 74 Successfully Completes Acquisition 74 Announces Dismissal 74 Regains Compliance With 74 Announce Early Termination 74 Q2 Profit Declines 74 Extends Reach 74 Announce Collaboration 74 Acquire Controlling Interest 74 Expands Relationship 74 Reports Second Quarter 74 Initiates Clinical Trial 74 Confirms 74 Increases Capacity 74 Receives Unsolicited 74 Increases Stake 74 Appoints 74 Issues Clarification 74 Extends Offer 74 Expands Relationship With 74 Completes Buyout 74 Extends Contract 74 Successfully Launches 74 Commences Initial 74 Enters Joint Venture 74 Receives Order 74 Announces Immediate Availability 74 Sign License Agreement 74 Awarded Contracts 74 Validates 74 Announces Normal Course 74 Finalize Agreement 74 Underwriters Exercise 74 Announces Second Quarter 74 Spins Out 74 Subsidiary Awarded 73 Unveils Next Generation 73 Inks Contract 73 Closes Buyout 73 Announces Upcoming 73 Voluntarily Withdraw 73 Receives Funding 73 Announces Sponsorship 73 Announce Definitive Agreement 73 Takes Delivery 73 Completes Reorganization 73 Explore Strategic Alternatives 73 Q3 Profit Rises 73 Shows Promise 73 Announces Dividend 73 News Unternehmensnachrichten 73 Announce Licensing Agreement 73 Subsidiary Enters Into 73 Declares Quarterly Dividends 73 Stockholders Approve Acquisition 73 Subsidiary Files 73 Files Preliminary Prospectus 73 Rebrands 73 Expands Into 73 Receives Approvals 73 Receives Milestone Payment 73 Reports Third Quarter 73 Reacquires 73 Acquires Exclusive 73 Snaps Up 73 Closes Oversubscribed 73 Strengthens Leadership 73 Successfully Demonstrates 73 Reschedules 73 Initiates Voluntary Recall 73 Achieves Record 73 Announces Record Date 73 Receives Requisite Consents 73 Expand Collaboration 73 Announces Operational Update 73 Swings To 73 Acquires Majority 73 FY# Loss Widens 73 Announces Participation 73 Achieves Record Sales 73 Q4 Profit Declines 73 Grants Options 73 Fortifies 73 Shares Surge 73 Enters Into Definitive 73 L.P. Announces 73 Concludes Acquisition 73 Announce Expanded 73 Acquires Majority Stake 73 Celebrates Opening 73 Receives Stockholder Approval 73 Introduces Innovative 73 Initiates Enrollment 73 Retains Investor Relations 73 Announces Bought Deal 73 Directors Authorizes 73 Signs Pact 73 Renews Contract 73 Q1 Profit Rises 73 Terminates Merger Agreement 73 Enters Negotiations 73 Strengthens Commitment 73 Exploring Strategic Alternatives 73 Confirms Significant 73 Q3 Profit Declines 73 Confirms Commitment 73 Engages 73 Announces Cash Dividend 73 Receives Orphan Drug Designation 73 4Q Loss Widens 73 Q1 Profit Declines 73 Commercializes 73 Forms Strategic 73 Closes Non Brokered 73 Reaffirms Commitment 73 Signs Memorandum 73 Achieves Certification 73 Accelerates 73 Beefs Up 73 Files Amended 73 Strengthens Presence 73 Inks Deal With 73 Extends Term 73 Moves Forward 73 IIROC Halt 72 Unveils Expanded 72 Maintains Strong 72 Expands 72 Shares Soar 72 Planned Acquisition 72 Moves Ahead 72 Begins Drilling 72 Achieves Positive 72 Commences Consent Solicitation 72 Exceeds Expectations 72 Unveils Latest 72 Undertakes 72 Announce Collaboration Agreement 72 CRWESelect CRWESelect.com Highlights 72 Q3 Profit Surges 72 Accelerates Growth 72 Certifies 72 Receives FDA Clearance 72 Clarifies Status 72 Receives Favorable Ruling 72 Stockholders Approve Merger Agreement 72 Awarded Patents 72 Announce Settlement 72 Sells Shares 72 FDA Clears 72 Announces Debt Settlement 72 Named Fastest Growing 72 Welcomes Analyst Initiation 72 Concludes Successful 72 Enters Into Licensing Agreement 72 Posts Record 72 Announces Retirement 72 Acquires Remaining 72 Repositions 72 Completes Reverse Merger 72 Amend Merger Agreement 72 Scoops Up 72 Secures 72 Initiates Phase 72 Announces Third Quarter 72 Posts Higher 72 Extends Collaboration 72 Completes Drilling 72 IIROC Resume 72 Announces Stock Buyback 72 Ranked Number 72 Repays 72 Files Patent 72 Announces Restatement 72 Q4 Profit Rises 72 Announces Tender Offers 72 Releases Next Generation 72 Delays Filing 72 Q4 Profit Surges 72 Files IND 72 Enters Into Letter 72 Broadens Its 72 Presents Positive 72 Reaches Milestone 72 Significantly Improves 72 Enters Into License Agreement 72 Re Affirms 72 Makes Significant 72 Subscribes 72 Arranges Financing 72 Earnings Postmortem 72 Inks Deal 72 Pending Acquisition 72 Has Commenced 72 Sign Licensing Agreement 72 Obtains License 72 Signs Exclusive 72 Schedules Third Quarter 72 Finalizes Contract 72 Files Annual Report 72 Attracting Bullish Investors 72 Acquires Remaining Interest 72 Expands Distribution 72 Approve Merger 72 Announce Merger 72 Schedules Second Quarter 72 Quadruples 72 Authorizes Additional 72 Expands Reach 72 Collaborators Present 72 Ramps Up 72 Reports Fiscal 72 Sign Definitive Merger 72 Jointly Develop 72 Expands Capacity 72 Recieves 72 Evaluate Strategic Alternatives 72 Initiates Clinical 72 Reclassifies 72 Joins OTCQX 72 Posts 4Q 72 Launches Innovative 72 Sweetens Bid 72 Investigates Proposed Acquisition 72 PROFILE CO 72 Receives Prestigious 72 Shares Climb 72 Strikes Deal 72 Doubles Capacity 72 CFO Resigns 72 Executes 71 Reschedules Fourth Quarter 71 Successfully Integrates 71 Reaches Settlement 71 Announces Affiliation 71 Unveils Revolutionary 71 Presents Preclinical Data 71 Regains Full 71 Delivers Next Generation 71 Signs Letter 71 Solidifies 71 Retains Leading 71 Zacks Analyst Blog Highlights 71 Has Received 71 Presents Positive Preclinical 71 Expands Availability 71 Statement Regarding 71 Lowers Guidance 71 Releases Latest 71 Enters Into Joint Venture 71 Post Earnings Checkup 71 Mobilizes 71 Reinforces 71 Shareholders Elect 71 Anounces 71 Rated Speculative Buy 71 Progresses 71 Issues Guidance 71 Bolsters 71 Q4 Profit Plunges 71 Sees Significant 71 Signs Joint Venture 71 Loss Widens 71 Announce Formation 71 Receives 71 Expands Deployment 71 Hits Milestone 71 Introduces Revolutionary 71 Continues Momentum 71 Settles Dispute 71 Unveils Innovative 71 Launches 71 Restates 71 Demonstrates Commitment 71 Renews Commitment 71 SWOT Analysis Aarkstore Enterprise 71 HSR Waiting Period 71 Results Confirm 71 Begins Shipment 71 Proudly Announces 71 Introduces Powerful 71 Assets Acquirer Company 71 Subsidiary Expands 71 Q2 Profit Surges 71 Q1 Profit Surges 71 Achieves Profitability 71 Receives Authorization 71 Reports Record 71 Announces Granting 71 Completes Non Brokered 71 Announcement Regarding 71 Ups Bid 71 Announces Quarterly Dividend 71 Enhances Customer 71 Subsidiary Wins 71 Signs Deal 71 Arranges 71 Remains Committed 71 Identifies Significant 71 Forges Partnership 71 Broadens 71 Reports Fourth Quarter 71 Announces Reverse Split 71 Bearish MACD 71 Achieves ISO #:# Certification [002] 71 Provides Comprehensive 71 Provides Shareholder 71 Forges Ahead 71 Declares Quarterly Cash Dividend 71 Schedules Fourth Quarter 71 Files Shelf Registration 71 Begins Shipping 71 Appoints Seasoned 71 Signs Reseller Agreement 71 Report Initiates Independent 71 Recommences 71 Study Demonstrates 71 Licenses Novel 71 Declares Increase 71 Provides Updated 71 Announces Mailing 71 Shares Plummet 71 Considers Sale 71 Remains Neutral 71 Nearing Completion 71 Announce Exclusive 71 3Q Loss Narrows 71 Terminate Merger Agreement 71 Conference Call TRANSCRIPT 71 Announces Effectiveness 71 Announce Partnership 71 Inks MOU 71 Revises Guidance 71 Extends Expiration 71 Increases Quarterly Cash Dividend 71 Completes Debt Refinancing 71 Commences Trading 71 Loss Narrows 71 Buys Majority Stake 71 Acquire Majority 71 Finalises 71 Announces Discontinuation 71 Initiates Phase III 71 Sells Stake 71 Marks Milestone 71 Sees Continued 71 Unveils Breakthrough 71 Commences Production 71 Renames 71 Moves Into 71 Subsidiary Purchases 71 Successfully Deploys 70 Acknowledges Receipt 70 Declares Fourth Quarter 70 Receives Recognition 70 Announces Webcast 70 Extend Partnership 70 Submits 70 Enters Into Negotiations 70 Ink Pact 70 Significantly Expand 70 Achieves SAS 70 Divests 70 Posts Narrower Loss 70 Moves Towards 70 Receives Notice From 70 Capital Invests 70 Reveals Positive 70 Stock Exchange Lists 70 Deploys 70 Files Revised 70 Inks Agreement 70 Holders Approve 70 Completes Spin Off 70 Host Third Quarter 70 Stays Neutral 70 Restructures Operations 70 Submits Biologics License Application 70 Acquire Remaining 70 Shareholders Overwhelmingly Approve 70 Introduces Breakthrough 70 Sets Second Quarter 70 Extends Deadline 70 Announces Timing 70 Pursues 70 Revises Fourth Quarter 70 Posts Wider 70 1Q Loss Narrows 70 Unveils Newest 70 Awarded Prestigious 70 Clears Path 70 Unveils Groundbreaking 70 Expand Into 70 Reach Agreement 70 Migrates 70 Q1 Adj 70 4Q Loss Narrows 70 Deliver Presentation 70 Q3 Profit Soars 70 Launches Website 70 Regains NASDAQ 70 &Amp; 70 Q2 Adj 70 Achieves Highest 70 Initiates Coverage 70 Movers Roundup 70 Shareholder Opinions 70 Holds Annual Meeting 70 Raises Bid 70 Receives Permit 70 Declares Cash Dividend 70 Restate Financial 70 Posts Quarterly 70 Successfully Implements 70 Submits Bid 70 Rejects Unsolicited 70 Proves Successful 70 Miraculins Announces 70 Q2 Profit Soars 70 2Q Loss Widens 70 Revolutionizes 70 Announce Shareholder Approval 70 Director Exercises Options 70 Study Confirms 70 Announces Partial Redemption 70 Successfully Completes Phase 70 Posts Lower 70 Announce Strategic 70 Sees Strong 70 Increases Quarterly Dividend 70 Boosts Buyback 70 Significant Increase 70 Wins Prestigious 70 Drilling Underway 70 Delivers Strong 70 Adopts Stockholder Rights 70 Host Fourth Quarter 70 Present Preclinical Data 70 Moves Closer 70 Commence Trading 70 Closes Flow Through 70 Identifies Potential 70 Enters Definitive Agreement 70 Files Voluntary 70 Reactivates 70 Posts Loss 70 Increases Non Brokered 70 Declares Second Quarter 70 1Q Profit Falls 70 Releases Statement Regarding 70 Successfully Delivers 70 Celebrates Successful 70 BayStreet.ca Research Alert 70 Joins Forces 70 Announces Appointments 70 Unitholders Approve 70 Chooses 70 Posts Profit 70 Settle Patent Litigation 70 Improves Customer 70 Negotiates 70 Cites Positive 70 Refocuses 70 Settle Patent Dispute 70 Demonstrates Significant 70 Arranges Private Placement 70 Extend Relationship 70 Signs Definitive Merger Agreement 70 Receives Highest 70 Narrows Guidance 70 Proposed Buyout 70 Signs Distribution 70 Sets Record Date 70 Narrows 4Q Loss 70 Shareholder Claims 70 Launches Redesigned Website 70 Reorganizes 70 Declares Increased 70 Dutton Associates Announces 70 Inc. OTCBB MNDP 70 Private Placement Closed 70 Seek Shareholder Approval 70 Expects Higher 70 Taglich Brothers Initiates Coverage 70 Shareholders Reject 70 Sets Record 70 Introduces 70 Mutually Agree 70 Acquire Stake 70 Momentum Continues 70 Gains Momentum 70 Q1 Profit Plunges 70 Announces Fourth Quarter 70 Formally Launches 70 Reveals 70 Receives Approval From 70 Receives Notice Regarding 70 Introduces Expanded 70 Buy Privately Held 70 Announces Definitive Merger 70 Earnings Rise 70 Commences Tender Offers 70 Fitch Withdraws Ratings 70 Q3 Profit Drops 69 Develops Innovative 69 Reports Significantly Improved 69 DayTradersDigest.com Profiles 69 Extends Leadership 69 3Q Loss Widens 69 Enters Into Settlement Agreement 69 Losses Narrow 69 Guides Inline 69 Dramatically Expands 69 Reduces Risk 69 Reach Settlement 69 Outlines Strategy 69 Revitalizes 69 Moves Toward 69 Reminds Shareholders 69 Study Indicates 69 Elevates 69 Renews Relationship 69 Settles Patent Litigation 69 Takes Stake 69 Withdraws Offer 69 Cuts Costs 69 Sets Quarterly Dividend 69 Deepens 69 Withdraws 69 Guides Below 69 Boosts Stake 69 Seeks Buyer 69 Investigates Buyout 69 Joins 69 Ceases 69 Has Entered 69 Unifies 69 Announce Reseller Agreement 69 Announce Termination 69 Bulks Up 69 Bodes Well 69 Ups Stake 69 Positions Itself 69 Regulators Approve 69 Achieves ISO # 69 Earns Prestigious 69 Initiates Dosing 69 Receives Positive Results 69 Files Lawsuit Against 69 Announces Delisting 69 Aligns 69 Inks Licensing Deal 69 Sets Date 69 CEO Exercises Options 69 Receives Contract 69 Increases Presence 69 Settle Litigation 69 Posts Solid 69 Prices Underwritten 69 1Q Loss Widens 69 Officially Launches 69 Posts 3Q Profit 69 Engages Investor Relations 69 Finalizes Purchase Of 69 Launches Unique 69 Fitch Assigns BBB 69 Postpones 69 Increases Private Placement 69 Mln Common 69 Reports Preclinical Data 69 Q1 Profit Soars 69 BioSante Pharmaceuticals Announces 69 Beats Analyst 69 Jointly Offer 69 Wraps Up 69 Mulls Sale 69 Completes Due Diligence 69 Sells Portion 69 Debuts Next Generation 69 Registration Statement Declared Effective 69 Host Webcast 69 Relocates Corporate Headquarters 69 Q4 Profit Soars 69 Announces Voluntary Recall 69 Solution Enables 69 Anticipates 69 Significantly Reduces 69 Renews 69 Gets Clearance 69 Receives Early Termination 69 Expands Commitment 69 Shareholders Approve Arrangement 69 Announces Spin Off 69 Amplifies 69 Extends Commitment 69 Announces Fiscal 69 Announces Profitable 69 Its Previously Announced 69 Announces Definitive Agreements 69 Declares Dividend 69 Provides Operational 69 Finalizes Sale Of 69 Collaborates With 69 Host Second Quarter 69 Winning Streak Continues 69 Reaches Agreements 69 #.#.# Meldung [001] 69 Releases Enhanced 69 Sharpens Focus 69 Implements 69 Extends 69 Forms Joint Venture 69 Confirms Filing 69 Successfully Demonstrate 69 Satisfies 69 Expands Footprint 69 Receives CE Marking 69 Action Filed Against 69 CFO Exercises Options 69 Finalizes Deal 69 Approves Merger 69 Posts 1Q 69 ValuEngine Upgrades 69 Announces Rebranding 69 Declares Regular Quarterly 69 Procures 69 Skymark Research Initiates Independent 69 Submits Revised 69 VP Exercises Options 69 Carries Out 69 Renews Partnership 69 Stock Soars 69 Patent Issued 69 Posts Narrower 69 Agreement Reached 69 Rolls Out 69 Sells Remaining 69 Takes Steps 69 Files Definitive Proxy 69 Starts Drilling 69 Awarded GSA Schedule 69 Files Preliminary Proxy 69 Achieves Record Revenue 69 Announces Reseller Agreement 69 Other OTC MNDP 69 Expands Offerings 69 Exercises Warrants 69 Re Elects 69 Obtains Patent 69 Posts 2Q 69 Stockholders Elect 69 Receives Anticipated 69 Declares Regular 69 Equity Preview 69 Co. Initiates Independent 69 Extends Consent Solicitation 69 Posts 4Q Profit 69 Outperforms 69 Enters Oversold Territory 69 TSX Delisting Review 69 Directors Elects 69 Unveils Enhanced 69 Hold Third Quarter 69 Submits IND 69 Delivers Enhanced 69 Changes Ticker Symbol 69 Sends Letter 69 Announce 69 Reveals Receipt 69 Signs Non Binding 69 Secures Patent 69 Reduces Workforce 69 Buys Stake 69 Succeeds 69 Record Third Quarter 69 Expands Coverage 69 Completes Offering 69 Action Suit Against 69 3Q Profit Rises 69 Daytradersdigest.com Profiles 69 Cash Tender Offers 68 AllPennyStocks.com Spotlights 68 Develop Next Generation 68 Commences Drilling 68 Signs Multi 68 Launches Breakthrough 68 Becomes Largest 68 Increases Share Repurchase 68 Begins Tender Offer 68 1st Writethru

Back to home page